154 related articles for article (PubMed ID: 9041347)
1. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
Bergelson JM; Modlin JF; Wieland-Alter W; Cunningham JA; Crowell RL; Finberg RW
J Infect Dis; 1997 Mar; 175(3):697-700. PubMed ID: 9041347
[TBL] [Abstract][Full Text] [Related]
2. Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line.
Riabi S; Harrath R; Gaaloul I; Bouslama L; Nasri D; Aouni M; Pillet S; Pozzetto B
J Biomed Sci; 2014 May; 21(1):50. PubMed ID: 24885774
[TBL] [Abstract][Full Text] [Related]
3. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
[TBL] [Abstract][Full Text] [Related]
4. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells.
Shieh JT; Bergelson JM
J Virol; 2002 Sep; 76(18):9474-80. PubMed ID: 12186929
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
6. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
[TBL] [Abstract][Full Text] [Related]
7. The replication of certain Coxsackie B virus strains in CHO cells.
Frisk G; Elfström T; Diderholm H
J Virol Methods; 2001 Nov; 98(2):161-5. PubMed ID: 11576643
[TBL] [Abstract][Full Text] [Related]
8. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
9. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
[TBL] [Abstract][Full Text] [Related]
10. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
[TBL] [Abstract][Full Text] [Related]
11. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.
Selinka HC; Wolde A; Sauter M; Kandolf R; Klingel K
Med Microbiol Immunol; 2004 May; 193(2-3):127-31. PubMed ID: 12920584
[TBL] [Abstract][Full Text] [Related]
12. Differences in inhibition of replication between Coxsackie B4 virus strains in various cell lines by antibodies to some cell surface proteins.
Frisk G; Jansson K; Ericsson M; Diderholm H
Virus Res; 2001 Mar; 73(2):121-30. PubMed ID: 11172916
[TBL] [Abstract][Full Text] [Related]
13. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.
Hsu KH; Lonberg-Holm K; Alstein B; Crowell RL
J Virol; 1988 May; 62(5):1647-52. PubMed ID: 2451756
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.
Crowell RL; Field AK; Schleif WA; Long WL; Colonno RJ; Mapoles JE; Emini EA
J Virol; 1986 Feb; 57(2):438-45. PubMed ID: 3003376
[TBL] [Abstract][Full Text] [Related]
16. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.
Reagan KJ; Goldberg B; Crowell RL
J Virol; 1984 Mar; 49(3):635-40. PubMed ID: 6321753
[TBL] [Abstract][Full Text] [Related]
17. Coxsackie B viruses use multiple receptors to infect human cardiac cells.
Orthopoulos G; Triantafilou K; Triantafilou M
J Med Virol; 2004 Oct; 74(2):291-9. PubMed ID: 15332279
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of disease in coxsackievirus B1 murine infection.
Cifuente JO; Ferrer MF; Jaquenod de Giusti C; Song WC; Romanowski V; Hafenstein SL; Gómez RM
J Med Virol; 2011 Sep; 83(9):1571-81. PubMed ID: 21739448
[TBL] [Abstract][Full Text] [Related]
20. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
